n(1)-methylnicotinamide has been researched along with Hypertension, Pulmonary in 1 studies
N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Progression of pulmonary hypertension is associated with the activation of the NNMT-MNA pathway in rats and humans." | 1.43 | Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension. ( Chlopicki, S; Fedorowicz, A; Jakubowski, A; Kopec, G; Kutryb-Zając, B; Mateuszuk, Ł; Skórka, T; Słomińska, E; Walczak, M; Zakrzewska, A; Łomnicka, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedorowicz, A | 1 |
| Mateuszuk, Ł | 1 |
| Kopec, G | 1 |
| Skórka, T | 1 |
| Kutryb-Zając, B | 1 |
| Zakrzewska, A | 1 |
| Walczak, M | 1 |
| Jakubowski, A | 1 |
| Łomnicka, M | 1 |
| Słomińska, E | 1 |
| Chlopicki, S | 1 |
1 other study available for n(1)-methylnicotinamide and Hypertension, Pulmonary
| Article | Year |
|---|---|
Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Animals; Case-Control Studies; Disease Models, Animal; Disease | 2016 |